Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by GoTogetheron Sep 18, 2017 3:10pm

156 Views

Post# 26710342

RE:RE:RE:RE:RE:PP = Win, Win Situation...

Hate to say it, but, wildbird1's, homework showed some flaws.
You can't make a prognosis based on Working Capital alone. This is simply not possible.

Another poster, 2b7f6fab, did a much better job:
From the 6/30 financials : Cash $932 K + Accounts Receivable $1344 K - Accounts Payable $ 592 K + Warrants Exercised after 6/30 $ 853 K - Operating Exp. @ $500 K / month estimate $ 1,500 K = $ 1000 K approximate cash balance at the end of September.

My estimation is somewhat more conservative : $ 500 K approximate cash balance at the end of September.

EOM.

Bullboard Posts

Changing Europe’s dependency on HREE from China